Abstract
ANTI-AMOEBIC DRUG: A FRIEND OF TUMMY AFTER EATING THE YUMMY & SPICY FOOD ENDS TOWARDS GUMMY EXCRETION

*Kushal Nandi, Smrutirekha Behera, Dr. Dhrubo Jyoti Sen and Dr. Dhananjoy Saha

ABSTRACT

Infection with the protozoan Entamoeba histolytica is common in low‐ and middle‐income countries, and up to 100,000 people with severe disease die every year. Adequate therapy for amoebic colitis is necessary to reduce illness, prevent development of complicated disease and extraintestinal spread, and decrease transmission. Amebiasis is an intestinal (bowel) illness caused by a microscopic (tiny) parasite called Entamoeba histolytica, which is spread through human feces (poop). Often there are no symptoms, but, sometimes it causes diarrhea (loose stool/poop), nausea (a feeling of sickness in the stomach), and weight loss. The parasite lives only in humans and is passed in the feces (poop) of an infected person. A person gets amebiasis by putting anything in their mouth that has touched infected feces or by eating or drinking food or water contaminated with the parasite. It can also be spread sexually by oral-anal contact. Some people with amebiasis may carry the parasite for weeks to years, often without symptoms, continually passing it in their feces. The majority of people who are infected with this parasite will experience no symptoms. Those who do become sick may experience mild or severe symptoms. The mild form of amebiasis includes nausea (a feeling of sickness in the stomach), diarrhea (loose stool/poop), weight loss, stomach tenderness, and occasional fever. Rarely, the parasite will spread the body beyond the intestines and cause a more serious infection, such as a liver abscess (a collection of pus). The symptoms may develop a few days to a few months after exposure but usually within two to four weeks.

Keywords: Amoebiosis, Metronidazole, Tinidazole, Anti Amoebiosis.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2024 Issue has been successfully launched on 1 MARCH 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT